-- EUROPE RESEARCH ROUNDUP- Nobel Biocare, OTP 
-- 
-- Wed Aug 27, 2014 12:58AM EDT
-- None



Aug 27 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Nobel Biocare and OTP, on Wednesday.

HIGHLIGHTS * Nobel Biocare <NOBN.S>: Jefferies cuts to underperform from hold; target to Sfr 13.50  * OTP <OTPB.BU>: Barclays raises to equal weight from underweight; cuts target to Huf 4230  Following is a summary of research actions on European companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.  * Aegon <AEGN.AS>: Morgan Stanley cuts target to 7.40 euros from 8.20 euros; overweight  * Ashtead Group <AHT.L>: Jefferies raises price target to 1,150p from 1,100p; rating buy * Autoneum <AUTON.S>: Credit Suisse cuts target to Sfr 170 from Sfr 180; rating neutral * Brenntag <BNRGn.DE>: UBS removes from European support services least preferred list * Eurazeo <EURA.PA>: SocGen raises target price to 62.5 euros from 60.5 euros; rating buy * Hannover Re <HNRGn.DE>: Barclays cuts target to 61 euros from 64.20 euros; equal weight * Hays <HAYS.L>: UBS removes from European support services most preferred list * Munich Re <MUVGn.DE>: Barclays cuts target to 158 euros from 160 euros; equal weight * Nobel Biocare <NOBN.S>: Jefferies cuts to underperform from hold * Nobel Biocare <NOBN.S>: Jefferies raises price target to Sfr 13.50 from Sfr 12.60 * OTP <OTPB.BU>: Barclays raises to equal weight from underweight * OTP <OTPB.BU>: Barclays cuts target price to Huf 4230 from Huf 4660 * Petrofac <PFC.L>: S&P Capital IQ raises to strong buy from buy